sCD30 concentration in cases and controls
sCD30 concentration, ng/mL . | Cases (N = 234) . | Controls (N = 234) . | P* . |
---|---|---|---|
All subjects | 18.8 (11.3-29.7)† | 13.5 (8.8-20.6) | < .001 |
By number of years from blood draw to case diagnosis | |||
1-2 (N = 62 matched pairs) | 18.3 (10.8-29.0) | 13.0 (8.9-20.2) | < .001 |
3-5 (N = 79) | 18.1 (11.9-33.9) | 14.4 (8.4-19.8) | < .001 |
6-10 (N = 93) | 19.8 (10.9-28.3) | 12.9 (9.2-21.3) | < .001 |
sCD30 concentration, ng/mL . | Cases (N = 234) . | Controls (N = 234) . | P* . |
---|---|---|---|
All subjects | 18.8 (11.3-29.7)† | 13.5 (8.8-20.6) | < .001 |
By number of years from blood draw to case diagnosis | |||
1-2 (N = 62 matched pairs) | 18.3 (10.8-29.0) | 13.0 (8.9-20.2) | < .001 |
3-5 (N = 79) | 18.1 (11.9-33.9) | 14.4 (8.4-19.8) | < .001 |
6-10 (N = 93) | 19.8 (10.9-28.3) | 12.9 (9.2-21.3) | < .001 |